Linking Alzheimer's and Atherosclerosis: New Insights
Research reveals connections between Alzheimer's and vascular health issues.
Beth Eyre, Kira Shaw, Dave Drew, Alexandra Rayson, Osman Shabir, Llywelyn Lee, Sheila Francis, Jason Berwick, Clare Howarth
― 7 min read
Table of Contents
- What is Alzheimer's Disease?
- The Role of Neurovascular Dysfunction
- The Connection between Alzheimer’s and Atherosclerosis
- Research on Atherosclerosis and Its Impact
- Investigating Cognitive Function
- The Study Setup
- Engaging with the Research Methods
- Results and Findings
- Analyzing Other Factors
- Pathological Findings
- Conclusion
- Original Source
- Reference Links
Imagine a world where more than fifty-five million people are living with dementia, a number expected to rise to over one hundred and thirty-nine million by 2030. Alzheimer's Disease is the most common reason behind this condition. People with Alzheimer's face a range of serious challenges, such as memory loss, confusion, and difficulties with thinking and reasoning. As we dig into this topic, we'll explore how Alzheimer's interacts with other health issues like atherosclerosis, which is caused by fat buildup in the arteries, and how these interactions affect the brain.
What is Alzheimer's Disease?
Alzheimer's disease, often referred to as AD, is a progressive brain disorder that leads to a gradual decline in Cognitive Functions. The brains of people with Alzheimer's are marked by the accumulation of proteins, such as amyloid beta plaques and hyperphosphorylated tau tangles. These changes disrupt communication between brain cells and can cause them to die, leading to the cognitive issues seen in the disease.
The greatest risk factor for developing Alzheimer's is age. As people get older, their chances of developing the disease increase. Many individuals with Alzheimer's also have other health problems, known as comorbidities, which can make their situation worse.
The Role of Neurovascular Dysfunction
New studies suggest that problems with blood vessels in the brain, known as neurovascular dysfunction, may play a crucial role in the development of Alzheimer's disease. Vascular risk factors such as diabetes, high blood pressure, and heart disease can damage the Blood-brain Barrier, which is like a protective wall that controls what enters the brain. When this barrier is damaged, it can lead to reduced blood flow to the brain, altering how proteins, like amyloid beta, are produced and cleared away.
An excess of amyloid beta can be harmful, contributing to neuron dysfunction and loss. This leads to the cognitive impairments that people with Alzheimer's experience.
The Connection between Alzheimer’s and Atherosclerosis
Atherosclerosis is like a pesky neighbor that doesn’t know when to leave. It is an inflammatory disease characterized by a buildup of fats in the arteries, which can reduce blood flow and is a leading cause of death in many countries. Research has linked atherosclerosis to Alzheimer's disease, with evidence showing that the two share common risk factors.
While understanding how both diseases interact is important, there isn't much research investigating how atherosclerosis affects brain blood flow and function in the context of Alzheimer's. Comorbid conditions can provide crucial insights into why some treatments for Alzheimer's do not translate well from animals to humans.
Research on Atherosclerosis and Its Impact
To study the effects of atherosclerosis, scientists have developed various animal models. One of the most popular methods is to create genetically modified mice that mimic the disease. But breeding these mice can be time-consuming and costly. Recently, researchers have explored new ways to induce atherosclerosis using viral vectors, which can make the process more efficient.
One study used these models to examine how atherosclerosis impacts brain function when combined with Alzheimer's. They found that in mice with both conditions, there were notable differences in how the brain responds to sensory stimulation.
Investigating Cognitive Function
Researchers often assess cognitive function in mice using a task called the Novel Object Recognition (NOR) test. This test takes advantage of mice’s natural curiosity towards novel objects. Mice are given a chance to explore two identical objects and later, one is replaced with a new one. The time spent with the new object indicates whether the mice recognize it as different from the familiar one.
When researchers conducted this test on mice with Alzheimer's, atherosclerosis, and a combination of both diseases, they found no significant differences in recognition memory among the groups. This suggests that even with the presence of these severe conditions, the mice were still able to recognize new objects similarly to healthy mice. However, the Alzheimer’s mice did spend less time with the new object than expected, hinting at some cognitive challenges.
The Study Setup
In studying these diseases, researchers used several techniques, including observing blood flow in the brain using a method called 2D optical imaging spectroscopy (2D-OIS). This allowed them to see how blood flowed in response to sensory stimulation over time. They also analyzed brain tissue to assess amyloid plaque loads and atherosclerotic plaque burden.
The study looked at male mice between 9-12 months old, spanning several groups: the normal (wild-type) group, the Alzheimer’s group, the atherosclerosis group, and the group with both diseases. The mice were housed in a controlled environment, ensuring they had the same conditions before experiments were conducted.
Engaging with the Research Methods
The Novel Object Recognition test was administered over two days. On the first day, the mice got familiar with the arena and the objects. On the second day, after a brief break, they were tested with one familiar object and one new one. Researchers recorded the time the mice spent with each object to calculate the preference for the novel one.
Post-experiment, the mice were sacrificed, and their brains were analyzed, revealing important information about amyloid levels and atherosclerotic plaques in the aorta.
Results and Findings
As researchers delved into the results, several patterns emerged. The atherosclerosis group showed reduced hemodynamic responses, especially during short stimuli. This means that their brains didn’t respond as robustly as the healthy group when a quick sensory stimulation was applied. However, during longer stimulation, the differences were less clear.
Interestingly, the addition of Alzheimer’s to atherosclerosis seemed to enhance some of the blood vessel responses. It raises questions about the interactions between the two diseases that researchers are eager to explore further.
Analyzing Other Factors
One major factor in these findings was locomotion. The movement of the mice during the testing impacted blood flow responses. When locomotion was accounted for, significant differences in hemodynamic responses across disease models diminished, indicating that the mice's movements influenced the results more than the underlying disease states.
This connection between locomotion and brain function suggests that when conducting future research, scientists need to pay attention to movement during experiments to ensure they are measuring what they intend to.
Pathological Findings
When it came to examining the pathology in the brain, researchers found no significant differences in amyloid burden between the Alzheimer’s and mixed disease groups. This was surprising to some because previous studies had shown that a combination of both diseases could lead to increased plaque load.
Similarly, there was no notable difference in the amount of atherosclerotic plaque between the atherosclerosis and mixed disease groups. The outcomes shed light on how two serious conditions can interact, and hinted at the need for further study.
Conclusion
The journey through understanding the interplay between Alzheimer's disease and atherosclerosis reveals both mysteries and insights. While these diseases can significantly affect life, researchers are working tirelessly to uncover mechanisms that could lead to better treatments.
As we continue to unravel the webs of neurodegeneration and vascular health, it remains crucial to remember the importance of experimental design and to consider factors like locomotion which can influence outcomes. This research paves the way for future studies that could help improve our understanding and treatment of these complex conditions.
So, next time you hear about someone's struggles with memory or heart health, remember that those challenges might just be the tip of an iceberg that's hiding a myriad of interactions in the body.
Title: Characterizing vascular function in mouse models of Alzheimer's disease, atherosclerosis, and mixed Alzheimer's and atherosclerosis
Abstract: SignificanceAlzheimers disease does not occur in isolation and there are many comorbidities associated with the disease - especially diseases of the vasculature. Atherosclerosis is a known risk factor for the subsequent development of Alzheimers disease, therefore understanding how both diseases interact will provide a greater understanding of co-morbid disease progression and aid the development of potential new treatments. AimThe current study characterizes hemodynamic responses and cognitive performance in APP/PS1 Alzheimers mice, atherosclerosis mice, and a mixed disease group (APP/PS1 & atherosclerosis) between the ages of 9 and 12 months. ApproachWhisker-evoked hemodynamic responses and recognition memory were assessed in awake mice, immunohistochemistry to assess amyloid pathology, and histology to characterize atherosclerotic plaque load. ResultsWe observed hemodynamic deficits in atherosclerosis mice (vs Alzheimers, mixed disease or wild-type mice), with reduced short-duration stimulus-evoked hemodynamic responses occurring when there was no concurrent locomotion during the stimulation period. Mixed Alzheimers and atherosclerosis models did not show differences in amyloid beta coverage in the cortex or hippocampus or atherosclerotic plaque burden in the aortic arch vs relevant Alzheimers or atherosclerosis controls. Consistent with the subtle vascular deficits and no pathology differences, we also observed no difference in performance on the novel object recognition task across groups. ConclusionsThese results emphasize the importance of experimental design for characterizing vascular function across disease groups, as locomotion and stimulus duration impacted the ability to detect differences between groups. Whilst atherosclerosis did reduce hemodynamic responses, these were recovered in the presence of co-occurring Alzheimers disease which may provide targets for future studies to explore the potentially contrasting vasodilatory mechanisms these diseases impact.
Authors: Beth Eyre, Kira Shaw, Dave Drew, Alexandra Rayson, Osman Shabir, Llywelyn Lee, Sheila Francis, Jason Berwick, Clare Howarth
Last Update: 2024-12-02 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.02.626393
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.02.626393.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.